Tag: STAT

STAT+: They advised federal health agencies on the ethics and impact of scientific research. They’re no longer wanted

Health and Human Services is undergoing significant changes in its advisory committees.Kayla Bartkowski/Getty Images For the past two

STAT+: The Supreme Court tackles medical malpractice

J. Scott Applewhite/AP Tara Bannow reports on the interplay between hospitals, providers, and insurance companies. For updates, reach

STAT+: As NIH launches new autism research effort, the focus is on environmental factors

Scientists are investigating how environmental elements like green areas and urban settings may affect autism prevalence.Brandon Bell/Getty Images

STAT+: Fights over Tylenol, SSRIs highlight the enduring lack of pregnant women in drug trials

Recent Actions by Administration Raise Concerns Over Tylenol and SSRIs for Pregnant Women Adobe Lizzy Lawrence, a leading

STAT+: Government shutdown set to furlough more than 32,000 at HHS, hamper CDC, CMS communication

WASHINGTON — The impending federal government shutdown is set to impact over 32,000 employees at the Department of

STAT+: As investor for AHA, ‘Venture Valkyrie’ argues ‘good medicine is good business’

Lisa Suennen: “We’re just steaming ahead with our eyes wide open.”American Heart Association Ventures Elizabeth Cooney is a

STAT+: Perimenopause is the new buzzword in the business of women’s health

By Sarah Todd Sept. 29, 2025 Reporter, Commercial Determinants of Health Unusual symptoms can begin to manifest for

STAT+: Harvard public health school confronts severe financial crisis, seeks corporate sponsors

By Kay Lazar and Jonathan Saltzman — Boston Globe Sept. 28, 2025 Harvard’s T.H. Chan School of Public

STAT+: Patients set to lose hospital care at home if government funding isn’t extended

By John Wilkerson and Mario Aguilar Sept. 26, 2025 A potential government shutdown could hinder physician payments and

STAT+: From an elixir for ‘little hotheads’ to deadly overdoses, how Tylenol became a medicinal scapegoat

Megan Molteni explores groundbreaking findings at the intersection of genomic medicine, neuroscience, and reproductive technology. She has been

STAT+: Anthony Letai of Dana-Farber is front-runner to lead National Cancer Institute

Angus Chen addresses a wide array of cancer-related topics, encompassing treatments, policy advancements, scientific discoveries, and health equity.

STAT+: Experimental gene therapy for Huntington’s markedly slowed disease progression in key trial

Groundbreaking Data Positions Uniqure's AMT-130 as Potential Pioneer Genetic Treatment for Huntington’s Disease Sipa via AP Images Adam